Paz De La Torre

Madrid, MD 28041, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A Cell-Based Therapeutic Strategy for Stress Urinary Incontinence: Functional and Molecular Evidence from Decidua-Derived Mesenchymal Stromal Cells.

A Cell-Based Therapeutic Strategy for Stress Urinary Incontinence: Functional and Molecular Evidence from Decidua-Derived Mesenchymal Stromal Cells.

Journal: International journal of molecular sciences
Published: July 02, 2026

Perinatal mesenchymal stromal cells of the human decidua restore continence in rats with stress urinary incontinence induced by simulated birth trauma and regulate senescence of fibroblasts from women with stress urinary incontinence.

Perinatal mesenchymal stromal cells of the human decidua restore continence in rats with stress urinary incontinence induced by simulated birth trauma and regulate senescence of fibroblasts from women with stress urinary incontinence.

Journal: Frontiers in cell and developmental biology
Published: August 31, 2022

New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies.

New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies.

Journal: Pharmaceutics
Published: November 18, 2021

Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells.

Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 04, 2021

Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy.

Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy.

Journal: Pharmaceutics
Published: December 31, 2020

Premature senescence of placental decidua cells as a possible cause of miscarriage produced by mycophenolic acid.

Premature senescence of placental decidua cells as a possible cause of miscarriage produced by mycophenolic acid.

Journal: Journal of biomedical science
Published: June 15, 2020

Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.

Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.

Journal: Molecules (Basel, Switzerland)
Published: December 13, 2019

Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region.

Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region.

Journal: Thrombosis and haemostasis
Published: July 11, 2018

Suicide-gene transfection of tumor-tropic placental stem cells employing ultrasound-responsive nanoparticles.

Suicide-gene transfection of tumor-tropic placental stem cells employing ultrasound-responsive nanoparticles.

Journal: Acta biomaterialia
Published: June 29, 2018

Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy.

Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy.

Journal: Nanoscale
Published: April 13, 2017

Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.

Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.

Journal: Stem cell research & therapy
Published: November 16, 2015

Decidua-derived mesenchymal stem cells as carriers of mesoporous silica nanoparticles. In vitro and in vivo evaluation on mammary tumors.

Decidua-derived mesenchymal stem cells as carriers of mesoporous silica nanoparticles. In vitro and in vivo evaluation on mammary tumors.

Journal: Acta biomaterialia
Published: September 08, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026